Literature DB >> 15963865

Association between symptom distress and survival in outpatients seen in a palliative care cancer center.

J Lynn Palmer1, Michael J Fisch.   

Abstract

Clinical observation and preliminary reports suggest that higher scores for symptoms such as pain may be associated with shorter survival. We undertook a survival analysis to determine whether symptom expression in outpatients with complex cancer is related to the duration of their survival. Participants were 225 outpatients with cancer evaluated in our comprehensive cancer center for pain management or palliative care over a 10-week period ending June 2000. In addition to age and other clinical and demographic information, the patients completed the Anderson Symptom Assessment System (ASAS), which assesses pain, fatigue, nausea, depression, anxiety, drowsiness, shortness of breath (dyspnea), appetite, sleep, and feeling of well-being on a 0-10 scale. Univariate analyses showed that higher symptoms of dyspnea, drowsiness, problems with appetite, and nausea were significantly associated with shorter survival whereas pain, depression and other ASAS items were not. In multivariate analyses, only higher levels of dyspnea and drowsiness showed a significant association (P=0.01 and P=0.02, respectively) with shorter survival. Knowledge about these symptoms may be important in formulating adaptive randomization techniques for clinical trials and for research concerning estimates of survival.

Entities:  

Mesh:

Year:  2005        PMID: 15963865     DOI: 10.1016/j.jpainsymman.2004.11.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

Review 1.  Neuro-oncology and palliative care: a challenging interface.

Authors:  Esther Lin; Mark A Rosenthal; Brian H Le; Peter Eastman
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 2.  [Management of refractory breathlessness in patients with advanced disease].

Authors:  C Bausewein
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

3.  Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.

Authors:  José M Garcia; John Friend; Suzan Allen
Journal:  Support Care Cancer       Date:  2012-06-16       Impact factor: 3.603

4.  Androgens and estrogens predict sexual function after autologous hematopoietic stem cell transplant in men.

Authors:  Lindsey J Anderson; Dorota Migula; Rebecca Abay; Stephanie Crabtree; Solomon A Graf; Alvin M Matsumoto; Thomas R Chauncey; Jose M Garcia
Journal:  Andrology       Date:  2021-11-25       Impact factor: 3.842

5.  Depression and cancer mortality: a meta-analysis.

Authors:  M Pinquart; P R Duberstein
Journal:  Psychol Med       Date:  2010-01-20       Impact factor: 7.723

6.  A longitudinal study of the role of patient-reported outcomes on survival prediction of palliative cancer inpatients in Taiwan.

Authors:  Jing-An Chang; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2009-02-12       Impact factor: 3.603

7.  Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study.

Authors:  Sang-Yeon Suh; Youn Seon Choi; Jae Yong Shim; Young Sung Kim; Chang Hwan Yeom; Daeyoung Kim; Shin Ae Park; Sooa Kim; Ji Yeon Seo; Su Hyun Kim; Daegyeun Kim; Sung-Eun Choi; Hong-Yup Ahn
Journal:  Support Care Cancer       Date:  2009-04-21       Impact factor: 3.603

8.  Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon.

Authors:  Huda Abu-Saad Huijer; Knar Sagherian; Hani Tamim
Journal:  Qual Life Res       Date:  2012-09-08       Impact factor: 4.147

Review 9.  Pain and symptom management in palliative care and at end of life.

Authors:  Diana J Wilkie; Miriam O Ezenwa
Journal:  Nurs Outlook       Date:  2012-09-14       Impact factor: 3.250

Review 10.  [Dyspnea : A challenging symptom in the primary care setting].

Authors:  Georg Fröhlich; Kai Schorn; Heike Fröhlich
Journal:  Internist (Berl)       Date:  2020-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.